Published in Intern Med J on January 04, 2010
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) (2013) 1.10
Anti-synthetase syndrome presenting as cryptogenic organizing pneumonia. Respir Med Case Rep (2012) 0.89
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study. Medicine (Baltimore) (2015) 0.83
A cardiorenal-pulmonary-cutaneous-muscle syndrome. Clin Kidney J (2013) 0.75
The Diagnosis and Treatment of Antisynthetase Syndrome. Clin Pulm Med (2016) 0.75
Syndrome in question: antisynthetase syndrome (anti-PL-7). An Bras Dermatol (2016) 0.75
Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies. Rheumatol Int (2011) 0.75
[Interstitial lung disease in polymyositis/dermatomyositis]. Z Rheumatol (2013) 0.75
A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet (1995) 2.57
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum (1997) 2.12
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child (2001) 2.07
Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol (1999) 1.88
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology (Oxford) (2003) 1.83
Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med (2007) 1.78
Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Arthritis Rheum (1996) 1.77
Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis. J Rheumatol (1997) 1.77
Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann Rheum Dis (1988) 1.69
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Prenatal maternal blood pressure response to stress predicts birth weight and gestational age: a preliminary study. Am J Obstet Gynecol (1996) 1.59
Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science (1973) 1.59
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Structure (1997) 1.51
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry (1997) 1.50
Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT)-treated patients. FASEB J (1992) 1.41
The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics (1992) 1.40
Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med (1997) 1.40
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol (1992) 1.39
Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis (1990) 1.33
600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase. Biopolymers (1999) 1.32
Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry (1999) 1.29
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1998) 1.27
Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet (1994) 1.25
The use of the hand anatomic index to assess deformity and impaired function in systemic sclerosis. Rheumatol Int (2005) 1.25
Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid. Ann Rheum Dis (1983) 1.22
Unconventional remedies used for patients with juvenile arthritis. Pediatrics (1990) 1.22
Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther (1992) 1.21
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 1.20
Structural abnormalities of the cricopharyngeus muscle in patients with pharyngeal (Zenker's) diverticulum. J Gastroenterol Hepatol (1993) 1.20
Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis (1976) 1.20
Large linkage analysis in 100 families with autosomal recessive spinal muscular atrophy (SMA) and 11 CEPH families using 15 polymorphic loci in the region 5q11.2-q13.3. Genomics (1994) 1.18
Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.18
Conserved water molecules contribute to the extensive network of interactions at the active site of protein kinase A. Proc Natl Acad Sci U S A (1998) 1.18
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child (2002) 1.15
Routine quantification of rheumatoid factor by rate nephelometry. Ann Rheum Dis (1985) 1.15
Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol (2002) 1.12
Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum (2001) 1.12
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies. Rheumatology (Oxford) (2001) 1.11
Circulating low molecular weight IgM--a disease marker in autoimmune, infective, immunodeficient and B cell lymphoproliferative disorders. Dis Markers (1993) 1.11
Lymphocyte subsets and inflammatory indices in synovial fluid and blood of patients with rheumatoid arthritis. J Rheumatol (1984) 1.10
The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline. Antiviral Res (1991) 1.10
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol (1999) 1.08
A nephelometric study of the reaction of monoclonal rheumatoid factor with heat aggregated gamma globulin and sera from patients with immune complex diseases. Clin Exp Immunol (1979) 1.07
A new scale to assess radiographic success of secondary alveolar bone grafts. Cleft Palate Craniofac J (2002) 1.07
Quantitation and evaluation of low molecular weight IgM in rheumatoid arthritis. Ann Rheum Dis (1980) 1.06
Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment. Ann Rheum Dis (2006) 1.05
Antimalarials. 16. Synthesis of 2-substituted analogues of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3- (trifluoromethyl)phenoxy]quinoline as candidate antimalarials. J Med Chem (1989) 1.05
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet (1995) 1.05
Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum (1981) 1.05
Primary biliary cirrhosis in mother and daughter. Br Med J (1977) 1.04
Acute effects of aerobic exercise on mood. Health Psychol (1988) 1.04
Quantitation of rheumatoid factor by laser nephelometry. Rheumatol Int (1982) 1.03
Test and teach. Number forty-four. Diagnosis: strongyloidiasis. Pathology (1983) 1.03
Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum (1996) 1.03
South Australian Scleroderma Register: analysis of deceased patients. Pathology (1998) 1.02
Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study. Ann Rheum Dis (1990) 1.02
The nature and assessment of general well-being. J Psychosom Res (1983) 1.02
Studies on the interaction of rheumatoid factor with monosodium urate crystals and case report of coexistent tophaceous gout and rheumatoid arthritis. Ann Rheum Dis (1985) 1.01
Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum (1986) 1.00
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer (2003) 1.00
Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations. Biochemistry (1998) 0.99
Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays. Ann Rheum Dis (1980) 0.98
Detection of first-order liquid/liquid phase transitions in yttrium oxide-aluminum oxide melts. Science (2008) 0.98
Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction (1999) 0.98
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood. J Rheumatol (1988) 0.98
The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agents Actions (1986) 0.98
Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J (2012) 0.97
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97
In vitro synthesis of low molecular weight IgM in rheumatoid arthritis. Arthritis Rheum (1985) 0.97
A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res (2001) 0.97
Visual field loss associated with vigabatrin: pathological correlations. J Neurol Neurosurg Psychiatry (2001) 0.97
A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust N Z J Med (1995) 0.96
Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann Rheum Dis (2005) 0.96
Relationship between paraprotein polymerization and clinical features in IgA myeloma. Br J Haematol (1976) 0.96
Antimalarials. 14. 5-(aryloxy)-4-methylprimaquine analogues. A highly effective series of blood and tissue schizonticidal agents. J Med Chem (1982) 0.96
From sequence to chromosome: the tip of the X chromosome of D. melanogaster. Science (2000) 0.96
Parental concern and distress about infant pain. Arch Dis Child Fetal Neonatal Ed (2004) 0.95
Towards efficient guidelines: how to monitor guideline use in primary care. Health Technol Assess (2003) 0.95
The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.95
The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs (2001) 0.95
Enteral feeding: practice guidance. Paediatr Nurs (2000) 0.95
Paraproteinemic crystalloidal keratopathy: an ultrastructural study of two cases, including immunoelectron microscopy. Ultrastruct Pathol (1994) 0.94
Monosodium urate crystal-induced prostaglandin synthesis in the rat subcutaneous air pouch. Clin Exp Rheumatol (1986) 0.94
Idiopathic inflammatory myopathies. Intern Med J (2009) 0.93
Functional malleability of the carboxyl-terminal tail in protein kinase A. J Biol Chem (1996) 0.93
Development of a panel of monochromosomal somatic cell hybrids for rapid gene mapping. Ann Hum Genet (1995) 0.93
Isolated pulmonary hypertension in scleroderma. Intern Med J (2005) 0.93
Identification of selective inhibitors of cyclin dependent kinase 4. Bioorg Med Chem Lett (2001) 0.93
Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy. Ann Rheum Dis (1989) 0.92
Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination. Prev Vet Med (2011) 0.92
High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. Tissue Antigens (2006) 0.92
A simple one-step procedure for preparation of C1-deficient human serum. J Immunol Methods (1984) 0.92
Appearance of low molecular weight IgM during course of infective endocarditis. Clin Exp Immunol (1986) 0.92
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo. Ann Rheum Dis (1990) 0.90
Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology (1992) 0.90